Antioxidant therapies in treating neurodegenerative diseases The modulation of antioxidant mechanisms to combat neurodegenerative diseases has sparked considerable interest among researchers [66,67,68,69,70]
This protocol maintains copper supplementation supporting collagen synthesis without full daily intensity, potentially sustaining 60-80% of peak benefits at 50-70% of continuous use cost while avoiding complete benefit decline from full discontinuation
Vitamin C: Ascorbic acid, or vitamin C, has antioxidant properties that brighten the skin by inhibiting melanin production and promoting collagen synthesis
Trusted pharmaceutical-grade product by Pfizer
Preclinical work also suggests amylin signalling interacts with mesolimbic dopaminergic pathways implicated in the hedonic, reward-driven component of eating a mechanism explored further in our overview of how cagrilintide influences brain satiety circuits and reward-driven eating
4,5,6,7 The important part of NAD+ is that its a long game